Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc. , a pioneer in ear, nose and throat (ENT) surgical
View HTML
Toggle Summary Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matrix (UBM) technology PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq:IART), today announced MicroMatrix® Flex is now available commercially in the U.S.
View HTML
Toggle Summary Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Reported revenues were $397.0 million, representing a decrease of 0.2% on a
View HTML
Toggle Summary Integra LifeSciences Announces Leadership Transition Plan
Jan De Witte to retire as CEO by the end of 2024 Stuart Essig appointed executive chairman of the Board PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (“Integra” or “the Company”) (NASDAQ: IART), a leading global medical technology company, today
View HTML
Toggle Summary Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, prior to the market open. In conjunction with
View HTML
Toggle Summary Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 42nd Annual J.P.
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
The acquisition will become part of Integra’s Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the neurosurgery segment. Provides a unique opportunity to build scale and capture a leadership position in
View HTML
Toggle Summary Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors
PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq: IART), a leading global medical technology company, today announced that Jeff Graves, Ph.D., president and chief executive officer of 3D Systems Corporation, was appointed to the company’s board
View HTML
Toggle Summary Integra LifeSciences Reports Third Quarter 2023 Financial Results
PRINCETON, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2023. Third Quarter 2023 Highlights Third quarter revenues of $382.4
View HTML
Toggle Summary Integra LifeSciences to Host Third Quarter 2023 Financial Results Conference Call on October 25, 2023
PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ: IART), a leading global medical technology company, will release third quarter 2023 financial results on Wednesday, October 25, 2023, prior to the market open. In conjunction with the earnings
View HTML
Toggle Summary Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2023 Wells Fargo Healthcare Conference on September 6, 2023 at 1:30
View HTML
Toggle Summary Integra LifeSciences Reports Second Quarter 2023 Financial Results
PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2023. Second Quarter 2023 Highlights Second quarter revenues of $381.3
View HTML
Toggle Summary Integra LifeSciences Announces Positive Clinical and Economic Outcomes for Codman® Bactiseal® EVD Catheter from a Real-World Evidence Study
Data Shows Codman Bactiseal EVD Catheter Reduced Hospital Stay and Costs Associated with Hemorrhagic Stroke Patients PRINCETON, N.J., July 6, 2023 -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced positive clinical and economic
View HTML
Toggle Summary Integra LifeSciences to Host Second Quarter 2023 Financial Results Conference Call on July 27, 2023
PRINCETON, N.J., July 03, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ: IART), a leading global medical technology company, will release second quarter 2023 financial results on Thursday, July 27, 2023, prior to the market open. In conjunction with the earnings
View HTML
Toggle Summary Integra LifeSciences Announces Complete Enrollment in DuraSorb® Monofilament Mesh U.S. IDE Study
Achieves Significant Milestone on Pathway to PMA Approval for Two-Stage Breast Reconstruction PRINCETON, N.J., June 28, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, announced the completion of patient enrollment in the
View HTML